Introduction: Yersinia enterocolitica includes both human pathogenic and non-pathogenic strains. The pathogenic strains belong to two evolutionary lineages: European and American, of mild- and high- pthogenicity, respectively. Y. enterocolitica European bioserotypes 4/O3 and 2/O9 are one of the major etiological agents of human yersiniosis worldwide. American lineage Y. enterocolitica bioserotype 1B/O8 has recently emerged in Europe. Since 2004 this high-pathogenicity bioserotype is increasingly isolated from humans in Poland. The rapid and accurate identification of pathogenic Y. enterocolitica strains is essential for diagnostic purposes. The aim of this study was to assess the usefulness of commercially available MALDI-TOF mass spectroscopy for Y. enterocolitica identification and subtyping.
Methods: A total of 33 strains of Y. enterocolitica belonging to bioserotype: 1B/O8 (n=2), 4/O3 (n=25) and 2/O9 (n=6) isolated from clinical specimens in Poland and 10 reference Y. enterocolitica 1B/O8 strains (Institute Pasteur, France) were used in this study. The identification of the Y. enterocolitica strains by MALDI-TOF MS was performed on MALDI Biotyper system (Bruker Daltonics, USA) with flexControl 3.0 software (Bruker Daltonics) according with the manufacturer's instruction.
Results: All of the tested Y. enterocolitica strains were correctly identified at the species level. However, American and European strains were not differentiated.
Conclusions: Our data indicate that MALDI-TOF MS can be used as a first-line method for rapid identification of Y. enterocolitica strains at the species level in clinical microbiology laboratories.
Download full-text PDF |
Source |
---|
FEMS Microbiol Lett
January 2025
Department of Molecular Biology and Genetics, Science Faculty, Ataturk University, 25240 Erzurum, Turkey.
In this study designed to isolate lactic acid bacteria (LAB) with bacteriocin production potential, white cheese samples were collected from different provinces of Turkey and isolation was carried out. A series of experiments were carried out for the main purpose and the actual bacteriocin producers were identified by detecting the genes encoding this bacteriocin. The experiments carried out in this direction were initially carried out with 20 isolates and as a result of various experiments, the number of isolates was reduced to 8 and the study was continued with 8 isolates.
View Article and Find Full Text PDFGene
March 2025
Área Microbiología e Inmunología, Facultad de Química, BioquímicaArgentina y Farmacia, Universidad Nacional de San Luis, Ejercito de los Andes 950, P. O. 5700 San Luis, Argentina. Electronic address:
Yersinia enterocolitica, a bacterial enteropathogen that produces a variety of clinical manifestations in humans, includes six biotypes (B), called 1A, 1B, 2, 3, 4 and 5 and about 70 serotypes. The biotypes exhibit diverse pathogenic potential; while 1B and 2-5 may show ability to produce clinical symptoms due to the presence of chromosomal and plasmid (pYV) virulence genes, B1A is supposed a non-pathogenic biotype since it lacks pYV plasmid. Therefore, although B1A strains cause diarrhea in humans, their pathogenic potential has not yet been extensively studied.
View Article and Find Full Text PDFFoodborne Pathog Dis
December 2024
School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
is one of the leading causes of bacterial foodborne diarrheal diseases throughout the world. Reported outbreaks of are infrequent in China. This article described such an outbreak among students from a junior high school in East China during November 2019.
View Article and Find Full Text PDFEnviron Pollut
January 2025
Military Medical Sciences Academy, Academy of Military Sciences, Tianjin Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, China. Electronic address:
Arch Virol
October 2024
Department of Biological and Environmental Science and Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
Yersinia enterocolitica causes yersiniosis, the third most common gastrointestinal infection in humans throughout Europe. The emergence of multidrug resistance and the lack of effective new antibiotics have drawn attention to phage therapy as a treatment option. Here, we report the complete genome sequence of phage fMtkYen3-01, which infects Y.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!